Effect of particle size of calcium phosphate based bioceramic drug delivery carrier on the release kinetics of ciprofloxacin hydrochloride: An in vitro study

Frontiers of Materials Science

Volumn 7, Issue 3, 2013, Pages 261-268

  Sasikumar, Swamiappan ^a  

^a VIT UNIVERSITY   (India)

Author keywords

antibiotic; ceramic drug delivery system; hydroxyapatite (HAP); porosity; targeted release

Indexed keywords

EID: 84881605877     PISSN: 2095025X     EISSN: 20950268     Source Type: Journal    
DOI: 10.1007/s11706-013-0216-6     Document Type: Article

References (19)

1. Cai L, Guinn A S, Wang S. Exposed hydroxyapatite particles on the surface of photo-crosslinked nanocomposites for promoting MC3T3 cell proliferation and differentiation. Acta Biomaterialia, 2011, 7(5): 2185-2199.
2. Laurent F, Bignon A, Goldnadel J, et al. A new concept of gentamicin loaded HAP/TCP bone substitute for prophylactic action: in vitro release validation. Journal of Materials Science: Materials in Medicine, 2008, 19(2): 947-951.
3. Jain A K, Panchagnula R. Skeletal drug delivery systems. International Journal of Pharmaceutics, 2000, 206(1-2): 1-12.
4. Shinto Y, Uchida A, Korkusuz F, et al. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. The Journal of Bone & Joint Surgery (British Volume), 1992, 74(4): 600-604.
5. Wahlig H. Gentamicin-PMMA beads: a drug delivery system in the treatment of chronic bone and soft tissue infections. Journal of Antimicrobial Chemotherapy, 1982, 10(5): 463-465.
6. Dunn M G, Bellincampi L D, Tria A J Jr, et al. Preliminary development of a collagen-PLA composite for ACL reconstruction. Journal of Applied Polymer Science, 1997, 63(11): 1423-1428.
7. Kopecek J. The potential of water-soluble polymeric carriers in targeted and site-specific drug delivery. Journal of Controlled Release, 1990, 11(1-3): 279-290.
8. Otsuka M, Nakahigashi Y, Matsuda Y, et al. Novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: The relationship between in vitro and in vivo drug release from indomethacin-containing cement. Journal of Controlled Release, 1997, 43(2-3): 115-122.
9. Sasikumar S, Vijayaraghavan R. Effect of metal-ion-to-fuel ratio on the phase formation of bioceramic phosphates synthesized by self-propagating combustion. Science and Technology of Advanced Materials, 2008, 9(3): 035003 (5 pages).
10. Han Y, Li S, Wang X, et al. Synthesis and sintering of nanocrystalline hydroxyapatite powders by citric acid sol-gel combustion method. Materials Research Bulletin, 2004, 39(1): 25-32.
11. Burgos A E, Belchior J C, Sinisterra R D. Controlled release of rhodium(II) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix. Biomaterials, 2002, 23(12): 2519-2526.
12. Rogers-Foy J M, Powers D L, Brosnan D A, et al. Hydroxyapatite composites designed for antibiotic drug delivery and bone reconstruction: a caprine model. Journal of Investigative Surgery, 1999, 12(5): 263-275.
13. Cohen S, Yoshioka T, Lucarelli M, et al. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharmaceutical Research, 1991, 8(6): 713-720.
14. Misiek D J, Kent J N, Carr R F. Soft tissue responses to hydroxylapatite particles of different shapes. Journal of Oral and Maxillofacial Surgery, 1984, 42(3): 150-160.
15. Bose S, Dasgupta S, Tarafder S, et al. Microwave-processed nanocrystalline hydroxyapatite: simultaneous enhancement of mechanical and biological properties. Acta Biomaterialia, 2010, 6(9): 3782-3790.
16. Castro C, Snchez E, Delgado A, et al. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. Journal of Controlled Release, 2003, 93(3): 341-354.
17. Cobby J, Mayersohn M, Walker G C. Influence of shape factors on kinetics of drug release from matrix tablets. I. Theoretical. Journal of Pharmaceutical Sciences, 1974, 63(5): 725-732.
18. Murugan R, Ramakrishna S. Designing biological apatite suitable for neomycin delivery. Journal of Materials Science, 2006, 41(13): 4343-4347.
19. Doadrio J C, Arcos D, Cabaas M V, et al. Calcium sulphate-based cements containing cephalexin. Biomaterials, 2004, 25(13): 2629-2635.